###begin article-title 0
###xml 18 23 18 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WDR36</italic>
###xml 39 47 <span type="species:ncbi:9606">patients</span>
Variations in the WDR36 gene in German patients with normal tension glaucoma
###end article-title 0
###begin title 1
Purpose
###end title 1
###begin p 2
###xml 31 36 31 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WDR36</italic>
###xml 77 85 <span type="species:ncbi:9606">patients</span>
To determine the prevalence of WDR36 sequence variants in a cohort of German patients with normal tension glaucoma.
###end p 2
###begin title 3
Methods
###end title 3
###begin p 4
###xml 55 60 55 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WDR36</italic>
All of the 23 coding exons and flanking introns of the WDR36 gene were amplified by PCR from genomic DNA and subjected to denaturing high performance liquid chromatography. Samples with aberrant profiles were sequenced. In addition, restriction fragment length polymorphism analysis was performed in order to identify previously described nucleotide changes.
###end p 4
###begin title 5
Results
###end title 5
###begin p 6
###xml 51 56 51 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WDR36</italic>
###xml 177 185 <span type="species:ncbi:9606">patients</span>
###xml 298 306 <span type="species:ncbi:9606">patients</span>
###xml 403 410 <span type="species:ncbi:9606">patient</span>
This study identified 11 nucleotide changes in the WDR36 gene that lead to predicted amino acid substitutions. Previously reported disease-causing mutations were found in 4% of patients (4/112) whereas sequence variants previously classified as disease-susceptibility mutations were found in 5% of patients (6/112). One nonsynonymous nucleotide change that has not been reported before was found in one patient. Mutation screening also identified several exonic and intronic polymorphisms.
###end p 6
###begin title 7
Conclusions
###end title 7
###begin p 8
###xml 48 53 48 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WDR36</italic>
The findings in the current study indicate that WDR36 gene variants may be only rare causes of normal tension glaucoma in the German population.
###end p 8
###begin title 9
Introduction
###end title 9
###begin p 10
###xml 181 182 181 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 320 321 320 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r2">2</xref>
###xml 359 367 <span type="species:ncbi:9606">patients</span>
The term glaucoma describes a heterogeneous group of optic neuropathies that lead to optic nerve atrophy and permanent loss of vision, affecting over 67 million subjects worldwide [1]. Since glaucoma rates rise exponentially with age, more glaucoma cases are expected in the future as the western population gets older [2]. The disease is insidious. Affected patients frequently have no symptoms, especially in the initial stages. When detected early, most cases can be successfully treated with medications, laser treatment, or surgery.
###end p 10
###begin p 11
###xml 315 323 <span type="species:ncbi:9606">Patients</span>
The hereditary forms of glaucoma are genetically heterogeneous. Primary open angle glaucoma (POAG) of adult onset is the most common form of glaucoma, representing approximately half of all cases. Normal tension glaucoma (NTG) is an important subtype of POAG, accounting for approximately 20-50% of all POAG cases. Patients with NTG show intraocular pressures that are within the statistical normal range of the population (10-20 mmHg).
###end p 11
###begin p 12
###xml 177 178 177 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r3">3</xref>
###xml 336 340 336 340 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 347 348 347 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r4">4</xref>
###xml 394 398 394 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 467 468 467 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r5">5</xref>
###xml 513 517 513 517 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 574 575 574 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r6">6</xref>
###xml 576 577 576 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r8">8</xref>
###xml 612 617 612 617 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLC1G</italic>
###xml 649 654 649 654 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WDR36</italic>
###xml 702 703 702 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 743 748 743 748 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WDR36</italic>
###xml 996 998 996 998 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r10">10</xref>
Despite the rather high prevalence and heritable nature of POAG, identification of causative genes has proven to be difficult. Though at least 20 loci have been linked to POAG [3], only two disease-causing genes for POAG have been identified until lately. A number of studies confirmed that about 4% of POAG cases show mutations in the MYOC gene [4]. Although mutations in the optineurin gene (OPTN) were initially reported in 16.7% of families with hereditary POAG [5], several other studies have indicated that OPTN sequence variants are only a rare cause of POAG or NTG [6-8]. Recently, a new locus for POAG (GLC1G) and the disease-causing gene (WDR36) have been identified by Monemi and coworkers [9]. In their study, mutation analysis of WDR36 in 130 unrelated affected individuals revealed a total of 25 allelic variants. The function of WDR36 and its role in the normal ocular physiology and glaucoma is still unclear, but WDR36 has been identified as being involved in T cell activation [10].
###end p 12
###begin p 13
###xml 61 66 61 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WDR36</italic>
###xml 117 125 <span type="species:ncbi:9606">patients</span>
The purpose of this study was to determine the prevalence of WDR36 sequence variants in a cohort of unrelated German patients with NTG.
###end p 13
###begin title 14
Methods
###end title 14
###begin title 15
###xml 27 35 <span type="species:ncbi:9606">patients</span>
Screening and selection of patients
###end title 15
###begin p 16
###xml 330 332 328 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
###xml 538 542 536 540 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 547 551 545 549 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 583 585 581 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
###xml 774 776 772 774 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 63 71 <span type="species:ncbi:9606">patients</span>
###xml 98 103 <span type="species:ncbi:9606">women</span>
###xml 111 114 <span type="species:ncbi:9606">men</span>
###xml 190 198 <span type="species:ncbi:9606">patients</span>
###xml 227 235 <span type="species:ncbi:9606">patients</span>
###xml 400 408 <span type="species:ncbi:9606">patients</span>
###xml 506 514 <span type="species:ncbi:9606">Patients</span>
###xml 1010 1018 <span type="species:ncbi:9606">Patients</span>
###xml 1310 1318 <span type="species:ncbi:9606">Patients</span>
###xml 2001 2013 <span type="species:ncbi:9606">participants</span>
The study population comprised a cohort of 112 unrelated white patients with NTG that included 67 women and 45 men. Their age range was 14-84 years with a mean age of 62.3+/-15.3. All study patients were part of a group of 289 patients that had been previously clinically investigated at the University Eye Hospital in Wuerzburg [11]. Selected from this group for molecular genetic analysis were 112 patients who had been followed long-term.This was to ensure diagnosis of NTG with a maximum of certainty. Patients have been screened for MYOC and OPTN mutations in a previous study [12]. Glaucoma was defined by the following strict criteria: (1) the presence of typical glaucomatous optic neuropathy with compatible visual field loss (according to Aulhorn classification) [13]; (2) open drainage angles on gonioscopy; and (3) absence of a secondary cause for glaucomatous optic neuropathy, such as a previously elevated intraocular pressure (IOP) after trauma, a period of steroid administration, or uveitis. Patients also did not have evidence of high myopia or congenital ocular abnormality, and had no other cause than glaucoma for disk changes and visual field loss. A neurological examination was performed in order to exclude an intracerebral expansion. Sonography was used to rule out aortic stenosis. Patients with untreated NTG had IOP measurements that were consistently 21 mmHg or lower on diurnal testing and during follow-up (IOP readings were correlated with corneal thickness). Disk size and parameters were evaluated by means of confocal examination (Heidelberg Retina Tomograph). Control DNA samples were obtained from 50 unrelated subjects of German descent who did not have a family history of glaucoma. Control individuals were age matched (mean age 60.5+/-18.7) and were collected from the same geographic region as the probands. A diagnosis of glaucoma was ruled out based on IOP measurements and ophthalmoscopy of the optic disk. Written informed consent was obtained from all participants. This study was approved by the ethics committees of the University Hospital Tuebingen and the University Hospital Wuerzburg. It was performed in accordance with the Helsinki Declaration.
###end p 16
###begin title 17
Detection of nucleotide variants by denaturing high performance liquid chromatography
###end title 17
###begin p 18
###xml 124 129 124 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WDR36</italic>
###xml 278 285 278 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
###xml 365 370 365 370 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WDR36</italic>
###xml 687 694 687 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t2">Table 2</xref>
###xml 763 765 763 765 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TM</sup>
###xml 0 7 <span type="species:ncbi:9606">Patient</span>
Patient DNA was extracted from peripheral blood lymphocytes using a standard salting-out procedure. Individual exons of the WDR36 gene were amplified by polymerase chain reaction (PCR) using appropriate amplification protocols. Primer pairs used for amplification are listed in Table 1. All amplicons containing the coding exons and neighboring intronic regions of WDR36 were screened for nucleotide changes with the WAVE denaturing high-performance liquid chromatography system (Transgenomic, Inc., Elancourt, France). The PCR products to be tested were mixed with an equimolar amount of a known unmutated PCR product to form heteroduplexes. Temperatures used for analysis are given in Table 2. The resulting DHPLC trace profiles were examined with the NavigatorTM software (Transgenomic, Inc.). The chromatographs were compared with the profile of wild-type DNA fragments. Samples with aberrant profiles were sequenced.
###end p 18
###begin title 19
###xml 39 44 39 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WDR36</italic>
Primer pairs used for amplification of WDR36.
###end title 19
###begin p 20
###xml 24 29 24 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WDR36</italic>
Individual exons of the WDR36 gene were amplified by polymerase chain reaction (PCR) using appropriate amplification protocols.
###end p 20
###begin title 21
###xml 77 82 77 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WDR36</italic>
Amplicon sizes and optimum temperatures for DHPLC analysis of all individual WDR36 exons.
###end title 21
###begin p 22
Temperatures used for denaturing high performance liquid chromatography. In the table, bp indicates base pairs.
###end p 22
###begin title 23
Mutation detection by direct sequencing
###end title 23
###begin p 24
PCR fragments were purified by ExoSAP-IT treatment (USB, Cleveland, OH), sequenced using Big Dye Termination chemistry (Applied Biosystems, Weiterstadt, Germany) and products separated on a DNA capillary sequencer (ABI 3100 Genetic Analyzer).
###end p 24
###begin title 25
Detection of nucleotide variants by restriction fragment length polymorphism analysis
###end title 25
###begin p 26
###xml 48 53 48 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WDR36</italic>
###xml 81 84 81 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hpy</italic>
###xml 183 186 183 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hpy</italic>
A 361 bp PCR product encompassing exon 8 of the WDR36 gene was digested with 1 U HpyCH4III restriction enzyme (NEB, Beverly, MA). The N355S missense change resulted in the gain of an HpyCH4III restriction site that, upon cleavage of the amplicon, produced two DNA fragments of 251 bp and 110 bp.
###end p 26
###begin p 27
###xml 49 54 49 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WDR36</italic>
###xml 82 85 82 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tse</italic>
###xml 165 169 165 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TseI</italic>
A 450 bp PCR product encompassing exon 11 of the WDR36 gene was digested with 1 U TseI restriction enzyme (NEB). The A449T missense change resulted in the loss of a TseI restriction site. Wild-type sequences were cleaved into two fragments of 229 bp and 221 bp.
###end p 27
###begin p 28
###xml 49 54 49 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WDR36</italic>
###xml 82 85 82 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Taq</italic>
###xml 165 168 165 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Taq</italic>
A 450 bp PCR product encompassing exon 13 of the WDR36 gene was digested with 1 U TaqI restriction enzyme (NEB). The R529Q missense change resulted in the loss of a TaqI restriction site. Wild-type sequences were cleaved into two fragments of 232 bp and 218 bp.
###end p 28
###begin p 29
###xml 49 54 49 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WDR36</italic>
###xml 82 85 82 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bgl</italic>
###xml 165 168 165 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bgl</italic>
A 282 bp PCR product encompassing exon 17 of the WDR36 gene was digested with 1 U BglI restriction enzyme (NEB). The D658G missense change resulted in the gain of a BglI restriction site that, upon cleavage of the amplicon, produced two DNA fragments of 233 bp and 49 bp. Restriction digests were analyzed on a 4% agarose gel.
###end p 29
###begin title 30
Results
###end title 30
###begin p 31
###xml 84 89 84 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WDR36</italic>
###xml 354 355 354 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 586 594 586 594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1</xref>
###xml 599 606 599 606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t3">Table 3</xref>
###xml 189 197 <span type="species:ncbi:9606">patients</span>
We screened the complete coding sequences plus flanking intron/UTR sequences of the WDR36 gene by denaturing high performance liquid chromatography (DHPLC) and subsequent sequencing in 112 patients with NTG. In addition, we performed RFLP analysis for four known sequence alterations that were judged in a previous study to be disease-causing mutations [9]. Of those four, we were able to identify three by RFLP analysis as well as with DHPLC and subsequent sequencing, namely A449T (found in two subjects), R529Q (found in one subject), and D658G (found in one subject), respectively (Figure 1 and Table 3). We were not able to detect any of these changes in 50 controls using DHPLC and RFLP analysis.
###end p 31
###begin p 32
###xml 67 68 67 68 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 184 189 184 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WDR36</italic>
###xml 210 211 210 211 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 386 387 386 387 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
Comparison of three mutation detection systems used in this study. A: Denaturing high performance liquid chromatography profiles of mutant (red) and wild-type (green) alleles of three WDR36 missense mutations. B: RFLP analysis. The following abbreviations were used: 100 bp ladder (M), restriction digest of mutant PCR product (Mut), and restriction digest of control PCR product (WT). C: DNA sequence analysis.
###end p 32
###begin title 33
###xml 72 77 72 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WDR36</italic>
Frequencies, localization, and putative functional effect of identified WDR36 sequence variants.
###end title 33
###begin p 34
###xml 36 41 36 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WDR36</italic>
Sequence variants identified in the WDR36 gene. The "Nucleotide change" column is based on GenBank accession number  and the "Prediction of functional effect" column is according to . In the table, ND refers to not determined.
###end p 34
###begin p 35
###xml 228 229 228 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 230 232 230 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r14">14</xref>
DHPLC analysis and subsequent sequencing also identified four additional nonsynonymous nucleotide changes, namely P31T, D33E, A163V, and H212P which were not present in 50 controls. The latter three have already been described [9,14], whereas this is the first report of P31T.
###end p 35
###begin p 36
###xml 154 161 154 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t3">Table 3</xref>
DHPLC screening and subsequent sequencing also revealed several synonymous polymorphisms (Q197Q, K564K, V714V, V727V) as well as 11 intronic alterations (Table 3). Neither a deletion/insertion nor a sequence alteration close to splice donor/acceptor sites change was found.
###end p 36
###begin p 37
###xml 63 67 63 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 76 80 76 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 120 122 120 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
###xml 178 183 178 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WDR36</italic>
###xml 5 13 <span type="species:ncbi:9606">patients</span>
###xml 131 139 <span type="species:ncbi:9606">patients</span>
Four patients harbored a potentially causative mutation in the OPTN gene or MYOC gene as was found in a previous study [12]. These patients did not show sequence variants in the WDR36 gene.
###end p 37
###begin title 38
Discussion
###end title 38
###begin p 39
###xml 49 54 49 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WDR36</italic>
###xml 252 253 252 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 88 96 <span type="species:ncbi:9606">patients</span>
This study describes mutational screening in the WDR36 gene in a large cohort of German patients with the NTG subtype of POAG. The primary aim of our study was to evaluate the prevalence of previously described mutations classified as disease causing [9]. Therefore, two different mutation-screening techniques (DHPLC and RFLP) were used to make sure that all four mutations (N355S, A449T, R529Q, and D658G) were detected.
###end p 39
###begin p 40
###xml 79 80 79 80 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 210 211 210 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 212 214 212 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r14">14</xref>
###xml 348 355 348 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t3">Table 3</xref>
###xml 360 368 360 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f2">Figure 2</xref>
###xml 931 933 931 933 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 1126 1134 1126 1134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f2">Figure 2</xref>
###xml 12 20 <span type="species:ncbi:9606">patients</span>
###xml 110 117 <span type="species:ncbi:9606">patient</span>
###xml 402 410 <span type="species:ncbi:9606">patients</span>
###xml 683 690 <span type="species:ncbi:9606">patient</span>
###xml 856 864 <span type="species:ncbi:9606">patients</span>
###xml 908 916 <span type="species:ncbi:9606">patients</span>
None of our patients had the N355S mutation described by Monemi and coworkers [9]. Instead, we identified one patient who harbored the R529Q mutation that has already been described in two independent studies [9,14]. According to the prediction program , this particular change lies in a highly conserved region and possibly has a damaging effect (Table 3 and Figure 2). In addition, we identified two patients with NTG who carried the A449T sequence variant. This mutation is not part of a known protein motif. It was not conserved and is therefore benign according to the  prediction. The D658G mutation noted in 3 out of 272 sporadic cases in the Monemi study was observed in one patient in the NTG group. In the former study this change was shown to be not present in 238 controls, whereas a case-control study on this particular variant in Australian patients demonstrated an equal distribution in both patients and controls [15]. Although this mutation leads to a conservative exchange of two polar and acidic residues, PolyPhen predicts this change to be probably damaging due to the high conservation between species (Figure 2).
###end p 40
###begin p 41
###xml 313 314 313 314 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 336 341 <span type="species:ncbi:9606">human</span>
Amino acid alignment and evolutionary conservation of non-synonymous changes identified in this study. Partial amino acid sequences of WDR36 protein orthologs from five different species were aligned to show possible conservation. Grey boxes highlight affected residues. P31T and D33E are not shown as the very NH2-terminal part of the human WDR36 protein was not conserved.
###end p 41
###begin p 42
###xml 194 195 194 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 196 198 196 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r14">14</xref>
###xml 313 320 <span type="species:ncbi:9606">patient</span>
In addition to the aforedescribed disease-causing mutations, we were able to identify sequence variants previously classified as disease-susceptibility mutations, namely D33E, A163V, and H212P [9,14]. We also noted one nonsynonymous nucleotide change (P31E) that has not been reported before. It was found in one patient in the NTG group and was not present in the control population. As the proline residue is not conserved between species (data not shown) and is not located in any known protein motif of WDR36, this change is probably benign.
###end p 42
###begin p 43
###xml 231 236 231 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WDR36</italic>
###xml 13 20 <span type="species:ncbi:9606">patient</span>
Although our patient and control cohort numbers were too small for a statistical analysis to determine whether the sequence variants we identified might be related to the disease, our results indicate that sequence variants of the WDR36 gene already described to be disease-causing are only rare causes of unrelated NTG in the German population.
###end p 43
###begin p 44
###xml 48 53 48 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WDR36</italic>
###xml 233 241 233 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1</xref>
###xml 397 402 397 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WDR36</italic>
###xml 1200 1205 1200 1205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WDR36</italic>
###xml 978 986 <span type="species:ncbi:9606">patients</span>
###xml 1116 1124 <span type="species:ncbi:9606">patients</span>
Apart from the findings of our study concerning WDR36 sequence variants, we observed that the results of the DHPLC screening in those exons that harbored already described mutations were consistent with the results of RFLP analysis (Figure 1). In addition, we identified several exonic and intronic polymorphisms by using DHPLC and subsequent sequencing. Therefore we reason that screening of the WDR36 gene with DHPLC gives rather reliable results compared with the hands-on time. Direct sequencing still represents the gold standard in mutation screening, and other screening mechanisms, such as DHPLC, are not as sensitive. Nevertheless, we are convinced that our screening procedure using DHPLC and RFLP gave comparable good detection rates. From our study it seems likely that DHPLC gives false positive results rather than false negative ones. Yet, we have to consider that we may have missed some nucleotide changes that could be associated with the NTG phenotype in our patients. In addition, as we only screened for mutations in exonic and flanking intron sequences, it is possible that a proportion of our patients carry mutations in the promoter region or in other regulatory sequences of WDR36. Screening with either DHPLC or direct sequencing does not reveal gross insertions or deletions that may be responsible for the phenotype.
###end p 44
###begin p 45
###xml 25 30 25 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WDR36</italic>
###xml 134 136 134 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
###xml 210 214 210 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 219 223 219 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 412 418 <span type="species:ncbi:9606">people</span>
Our study indicates that WDR36 sequence variants are only rare causes of unrelated NTG in the German population. In a previous study [12], we showed this also holds true for the other two POAG-associated genes MYOC and OPTN. As early diagnosis is critical for successful treatment of glaucoma, defining the genetic basis of hereditary forms of glaucoma is an important step towards a presymptomatic screening of people at risk. However, a routine genetic testing for the three known POAG-associated genes seems to be of limited value due to the low prevalence of disease-causing mutations.
###end p 45
###begin p 46
A considerable number of studies dealing with the genetics of glaucoma have shown that only a small proportion of glaucoma cases are due to monogenic forms. The vast majority of cases are inherited as a complex trait. Therefore, genome-wide association studies might be a better strategy to use in defining genetic profiles for those at risk for developing glaucoma.
###end p 46
###begin title 47
References
###end title 47
###begin article-title 48
###xml 10 16 <span type="species:ncbi:9606">people</span>
Number of people with glaucoma worldwide.
###end article-title 48
###begin article-title 49
The projected increase in glaucoma due to an ageing population.
###end article-title 49
###begin article-title 50
Gene mapping for primary open angle glaucoma.
###end article-title 50
###begin article-title 51
Heredity in primary open-angle glaucoma.
###end article-title 51
###begin article-title 52
Adult-onset primary open-angle glaucoma caused by mutations in optineurin.
###end article-title 52
###begin article-title 53
The role of TIGR and OPTN in Finnish glaucoma families: a clinical and molecular genetic study.
###end article-title 53
###begin article-title 54
###xml 89 97 <span type="species:ncbi:9606">patients</span>
The association between Japanese primary open-angle glaucoma and normal tension glaucoma patients and the optineurin gene.
###end article-title 54
###begin article-title 55
###xml 63 71 <span type="species:ncbi:9606">patients</span>
Lack of association of mutations in optineurin with disease in patients with adult-onset primary open-angle glaucoma.
###end article-title 55
###begin article-title 56
Identification of a novel adult-onset primary open-angle glaucoma (POAG) gene on 5q22.1.
###end article-title 56
###begin article-title 57
T lymphocyte activation gene identification by coregulated expression on DNA microarrays.
###end article-title 57
###begin article-title 58
###xml 90 98 <span type="species:ncbi:9606">patients</span>
Prevalence of myocilin and optineurin sequence variants in German normal tension glaucoma patients.
###end article-title 58
###begin article-title 59
Frequency distribution in early glaucomatous visual field defects.
###end article-title 59
###begin article-title 60
###xml 47 55 <span type="species:ncbi:9606">patients</span>
Distribution of WDR36 DNA sequence variants in patients with primary open-angle glaucoma.
###end article-title 60
###begin article-title 61
A Glaucoma Case-control Study of the WDR36 Gene D658G sequence variant.
###end article-title 61

